Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study

By sjmartinez • May 9, 2024

Dacic S, Travis WD, Giltnane JM, Kos F, Abel J, Hilz S, Fujimoto J, Sholl L, Ritter J, Khalil F, Liu Y, Taylor-Weiner A, Resnick M, Yu H, Hirsch FR, Bunn PA Jr, Carbone DP, Rusch V, Kwiatkowski DJ, Johnson BE, Lee JM, Hennek SR, Wapinski I, Nicholas A, Johnson A, Schulze K, Kris MG, Wistuba II. Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study. J Thorac Oncol. 2024 May;19(5):719-731. doi: 10.1016/j.jtho.2023.12.010. Epub 2023 Dec 7. PMID: 38070597.

Tags: Artificial intelligence, Convolutional neural network, digital pathology, neoadjuvant, NSCLC, Publications, Pulmonary, Critical Care & Sleep Medicine

The Family Perspectives Project: development and preliminary feasibility of a chaplain-delivered emotional support intervention for families of critically ill patients

Modes ME, Kross EK, Duru OK, Sherman A, Ahluwalia SC, Walling AM, Lazor P, Nuckols TK. The Family Perspectives Project: development and preliminary feasibility of[...]

Regional heterogeneity and sex differences along the mouse aorta

Sveeggen TM, Kosmach A, Mitchell R, Brockmann BC, Meisinger TM, Stratman AN, Mack JJ, Cook JR, Bagher P. Regional heterogeneity and sex differences along the[...]

Cost Offset With Quadruple Therapy for Heart Failure

Keykhaei M, Rashedi S, Greene SJ, Yancy C, Ziaeian B, Sandhu AT, Kittleson M, Fonarow GC. Cost Offset With Quadruple Therapy for Heart Failure. JAMA[...]